These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 8948000)

  • 21. [Presentation of obsessive-compulsive symptoms in a patient with schizophrenia treated with clozapine].
    Stengler-Wenzke K
    Psychiatr Prax; 1999 May; 26(3):145-6. PubMed ID: 10412713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
    Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
    J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risperidone after clozapine in therapy refractory schizoaffective psychosis--a case report].
    Konrad C; Schormair C; Eikelmann B; Telger K
    Psychiatr Prax; 1997 Mar; 24(2):88-9. PubMed ID: 9190618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Creativity and antipsychotic drugs].
    Murry P; Torrecuadrada JL
    Encephale; 1997 Sep; 23 Spec No 4():17-9. PubMed ID: 9417399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of clozapine and risperidone: a review of recent literature.
    Byerly MJ; DeVane CL
    J Clin Psychopharmacol; 1996 Apr; 16(2):177-87. PubMed ID: 8690833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview.
    Kane JM
    Br J Psychiatry Suppl; 1992 May; (17):41-5. PubMed ID: 1418888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrapyramidal syndromes and new antipsychotic drugs: findings in patients and non-human primate models.
    Casey DE
    Br J Psychiatry Suppl; 1996 May; (29):32-9. PubMed ID: 8733821
    [No Abstract]   [Full Text] [Related]  

  • 28. Acute dystonic reaction with risperidone.
    Takhar J; Manchanda R
    Can J Psychiatry; 1996 Feb; 41(1):61-2. PubMed ID: 8919428
    [No Abstract]   [Full Text] [Related]  

  • 29. Conventional versus atypical neuroleptics: subjective quality of life in schizophrenic patients.
    Franz M; Lis S; Plüddemann K; Gallhofer B
    Br J Psychiatry; 1997 May; 170():422-5. PubMed ID: 9307690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clozapine-related extrapyramidal side effects: a case report.
    Gallo M; Squarcione C; Bersani FS; Minichino A; Fojanesi M; Biondi M
    Riv Psichiatr; 2017; 52(4):172-173. PubMed ID: 28845867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Addressing adverse effects of antipsychotic treatment in young patients with schizophrenia.
    Correll CU
    J Clin Psychiatry; 2011 Jan; 72(1):e01. PubMed ID: 21272508
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extrapyramidal side-effect due to drug combination of risperidone and donepezil.
    Liu HC; Lin SK; Sung SM
    Psychiatry Clin Neurosci; 2002 Aug; 56(4):479. PubMed ID: 12109969
    [No Abstract]   [Full Text] [Related]  

  • 33. Will the novel antipsychotics significantly ameliorate neuropsychological deficits and improve adaptive functioning in schizophrenia?
    Hawkins KA; Mohamed S; Woods SW
    Psychol Med; 1999 Jan; 29(1):1-8. PubMed ID: 10077288
    [No Abstract]   [Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome associated with risperidone in a male with early-onset schizophrenia.
    Mané A; Baeza I; Morer A; Lázaro ML; Bernardo M
    J Child Adolesc Psychopharmacol; 2005 Dec; 15(6):844-5. PubMed ID: 16379503
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome.
    Lieberman JA; Safferman AZ; Pollack S; Szymanski S; Johns C; Howard A; Kronig M; Bookstein P; Kane JM
    Am J Psychiatry; 1994 Dec; 151(12):1744-52. PubMed ID: 7977880
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphocytopenia and thrombocytopenia during treatment with risperidone or clozapine.
    Assion HJ; Kolbinger HM; Rao ML; Laux G
    Pharmacopsychiatry; 1996 Nov; 29(6):227-8. PubMed ID: 8956354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The new atypical antipsychotics. A lack of extrapyramidal side-effects and new routes in schizophrenia research.
    Kerwin RW
    Br J Psychiatry; 1994 Feb; 164(2):141-8. PubMed ID: 7513599
    [No Abstract]   [Full Text] [Related]  

  • 38. Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy.
    Carnahan RM; Lund BC; Perry PJ; Chrischilles EA
    Acta Psychiatr Scand; 2006 Feb; 113(2):135-41. PubMed ID: 16423165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience in developing treatment regimens with the novel antipsychotic risperidone.
    Kopala LC
    Int Clin Psychopharmacol; 1997 Sep; 12 Suppl 4():S11-8. PubMed ID: 9352341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroleptics and the extrapyramidal system].
    Haase HJ
    Arzneimittelforschung; 1978; 28(9):1536-7. PubMed ID: 38814
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.